These compounds may interact with:
Insulin receptor
Potentially involved in: donohue syndrome; polycystic ovary syndrome; diabetes mellitus; gout; hypothyroidism; carcinoma; retinal disease; acanthosis nigricans; hyperinsulinism; obesity; hyperglycemia; hypertrichosis; cancer; hyperandrogenism; abdomen distended; acromegaly; alzheimer's disease; cachexia; cholestasis; diabetes mellitus, experimental
Disease data sourced from Pharos.